Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
A review of Xie et al., "The molecular similarity landscape of preclinical cancer models to patient tumors," JCI Insight (2026) Model selection is one…
Read more
Advances in hormonal therapies, precision medicine, radiopharmaceuticals, and molecular diagnostics have expanded treatment options for prostate cance…
Read more
As precision oncology continues to reshape cancer research, understanding the molecular drivers of prostate cancer has become essential for translatio…
Read more
